NEWS 14 FEED & ADDITIVE MAGAZINE February 2024 Following several acquisitions, including Klifovet, Pen & Tec Consulting, and Ondax Scientific, Argenta rings in the new year by bringing its businesses together under one, energised brand. The combined identity reflects the company’s enhanced offering to customers, providing them with unparalleled, comprehensive support right across the animal health product development cycle from ‘molecule to market.’ According to the company's statement, Argenta already held a unique position as the world’s only combined CRO and CDMO dedicated to animal health, partnering with clients big and small for more than 17 years on the pathway from concept to market. The acquisition of Klifovet, Pen & Tec Consulting, and Ondax Scientific has strengthened this offering, and joining together under one brand reflects a determination to maximise the group’s collective capabilities and global footprint to help more clients improve the health of pets and livestock, and achieve their commercial goals. Argenta stated that the good news for customers is that there will be no changes to legal entities and who they do business with, and they’ll continue to work with the same experienced contacts at Argenta but will now have easier access to a greater range of expertise and capabilities as their requirements evolve. “As we’ve grown in recent years, we’ve brought some great companies into the group, expanding our offering to customers and strengthening Argenta’s position as the world’s only combined CRO and CDMO dedicated to animal health,” said Will Downie, CEO of Argenta. Read more>> Argenta combines legacy brands to further advance animal health Adisseo announces new plans for methionine production Adisseo, one of the world's leading manufacturers of feed supplements for animal nutrition, is planning to concentrate all its French powder methionine production at Roches-Roussillon. This project aims to safeguard the competitiveness of Adisseo's methionine activities in Europe by adapting its industrial facilities to an increasingly competitive environment. In this context, it is planned not to restart the powder methionine workshop at the Commentry site, which has already been shut down since October 2022 because of the structural deterioration in market conditions. In its statement, the company emphasized: • Worldwide, methionine production capacity has been growing faster than demand, leading to a mismatch between supply and demand, particularly in Europe, where demand for powdered methionine is falling. • The utilization rate of industrial tools worldwide is set to fall by around 15% between 2023 and 2026, to 80%, compared with almost 95% in 2018. After taking the time to conclude that no option would restore this plant's competitiveness, Adisseo is forced to decide not to restart it. As a result, 47 net jobs are to be cut at the Commentry site, out of a total workforce of 335 (as of December 1, 2023). To provide the best possible support for each employee concerned, an internal redeployment and voluntary redundancy plan would initially be set up, and the measures of a robust job protection plan would be negotiated with the trade unions. Read more>>
RkJQdWJsaXNoZXIy MTUxNjkxNQ==